Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Cancer Letters|December 12, 2025
Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung CancerYuan Gao, Lee X Li, Andrew Rowland, et al.
JCO Precision Oncology|February 14, 2023
Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With CancerAshley M Hopkins, Michael J Sorich, Andrew J McLachlan, et al.
Journal of Clinical Epidemiology|November 23, 2025
Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitorsLee X Li, Ashley M Hopkins, Richard Woodman, et al.
The AAPS Journal|September 1, 2021
Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by ClarithromycinAsha J Kapetas, Ahmad Y Abuhelwa, Michael J Sorich, et al.
JAMA Network Open|September 23, 2024
Gender Representation of Health Care Professionals in Large Language Model-Generated StoriesBradley D Menz, Nicole M Kuderer, Benjamin Chin-Yee, et al.
F1000Research|February 9, 2017
Targeted pharmacotherapy after somatic cancer mutation screeningThomas M Polasek, Karen Ambler, Hamish S Scott, et al.
Pharmacology Research & Perspectives|July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicinesAshley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
British Journal of Cancer|September 27, 2017
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markersAshley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, et al.
Microorganisms|September 27, 2025
<i>Acanthospermum australe</i> Extract Inhibits the Chaperone Activity of <i>Plasmodium falciparum</i> Heat Shock Protein 70-1Ntombikhona Appear Koza, Ntokozo Nkosinathi Myeza, Heinrich Hoppe, et al.
Physiological Reviews|February 7, 2019
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel ParadigmsRobyn Meech, Dong Gui Hu, Ross A McKinnon, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Cancer Letters|December 12, 2025
Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung CancerYuan Gao, Lee X Li, Andrew Rowland, et al.
JCO Precision Oncology|February 14, 2023
Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With CancerAshley M Hopkins, Michael J Sorich, Andrew J McLachlan, et al.
Journal of Clinical Epidemiology|November 23, 2025
Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitorsLee X Li, Ashley M Hopkins, Richard Woodman, et al.
The AAPS Journal|September 1, 2021
Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by ClarithromycinAsha J Kapetas, Ahmad Y Abuhelwa, Michael J Sorich, et al.
JAMA Network Open|September 23, 2024
Gender Representation of Health Care Professionals in Large Language Model-Generated StoriesBradley D Menz, Nicole M Kuderer, Benjamin Chin-Yee, et al.
F1000Research|February 9, 2017
Targeted pharmacotherapy after somatic cancer mutation screeningThomas M Polasek, Karen Ambler, Hamish S Scott, et al.
Pharmacology Research & Perspectives|July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicinesAshley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
British Journal of Cancer|September 27, 2017
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markersAshley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, et al.
Microorganisms|September 27, 2025
<i>Acanthospermum australe</i> Extract Inhibits the Chaperone Activity of <i>Plasmodium falciparum</i> Heat Shock Protein 70-1Ntombikhona Appear Koza, Ntokozo Nkosinathi Myeza, Heinrich Hoppe, et al.
Physiological Reviews|February 7, 2019
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel ParadigmsRobyn Meech, Dong Gui Hu, Ross A McKinnon, et al.
Pageof 19